Clover Health (CLOV) PT Lowered to $5 at Craig-Hallum
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLOV Hot Sheet
Price: $4.69 +9.32%
Rating Summary:
4 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
4 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Craig-Hallum analyst Matt Hewitt lowered the price target on Clover Health (NASDAQ: CLOV) to $5.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- UBS Downgrades PagSeguro (PAGS) to Neutral
- Varroc Engineering Ltd (VARROC:IN) PT Lowered to INR880 at ICICI Securities
- Prince Pipes & Fittings (PRINCPIP:IN) PT Raised to INR343 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
